Conclusions: Approximately one in seven patients with CTEPH harbours a congenital thrombophilia, most often protein S or protein C deficiency, whereas classic venous-thrombo-embolism mutations are rare and ethnically restricted. This evidence concerns the gene PROS1 and chronic thromboembolic pulmonary hypertension.